Home » Wyeth Obtains EU Positive Opinion for Pneumococcal Conjugate Vaccine
Wyeth Obtains EU Positive Opinion for Pneumococcal Conjugate Vaccine
Wyeth Pharmaceuticals, a division of Wyeth, has reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion for the company’s pneumococcal conjugate vaccine, Prevenar 13.
TradingMarkets
TradingMarkets
Upcoming Events
-
07May
-
14May
-
30May